Announcement
On 15 October 2026, NTL Healthcare, a women's health artificial intelligence company based in Seongnam, South Korea, announced the global launch of CerviCARE® AI AT, an on‑premises version of its existing CerviCARE® AI cervical screening platform.
Product Details
CerviCARE® AI AT is installed on local personal computers within healthcare institutions and operates without requiring a dedicated server or cloud infrastructure. The on‑premises architecture allows AI analysis and related data management to remain inside the institution’s IT environment, reducing the need to transmit or store cervical images externally. The solution retains all core AI analysis capabilities and key features of the SaaS version, while adding the ability to generate DICOM files, enabling cervical images and associated information to be stored in the standardized medical imaging format.
Deployment Options
With this launch, NTL Healthcare now offers two deployment models for CerviCARE® AI: the existing SaaS cloud‑based service and the new on‑premises CerviCARE® AI AT. Institutions can select the model that aligns with their internal security policies, IT infrastructure, and data‑management requirements.
Executive Comment
Tae‑hee Kim, CEO of NTL Healthcare, stated that “as global adoption of medical AI continues to grow, healthcare institutions are placing increasing importance not only on AI performance but also on how medical data is processed and managed within their own IT environments.” He added that the launch “represents an expansion of the CerviCARE® AI platform” and that the company will continue to broaden flexible deployment options to meet diverse institutional needs.
Distribution
The announcement was distributed via PRNewswire under an arrangement with the news agency, with a disclaimer that PTI assumes no editorial responsibility for the content.